A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset

dc.authorscopusid 6601988964
dc.authorscopusid 7005152947
dc.authorscopusid 35584298800
dc.authorscopusid 58685662800
dc.authorscopusid 55767240300
dc.authorscopusid 55357185100
dc.authorscopusid 35474297200
dc.contributor.author Altiok,E.
dc.contributor.author Aksoy,F.
dc.contributor.author Perk,Y.
dc.contributor.author Taylan,F.
dc.contributor.author Kim,P.W.
dc.contributor.author Ilkkan,B.
dc.contributor.author Sanal,O.
dc.date.accessioned 2024-05-25T12:31:12Z
dc.date.available 2024-05-25T12:31:12Z
dc.date.issued 2012
dc.department Okan University en_US
dc.department-temp Altiok E., Department of Medical Biology, Acibadem University Faculty of Medicine, Istanbul, Turkey, Department of Genetics and Bioengineering, Okan University, Tuzla, Istanbul 34959, Turkey; Aksoy F., Department of Pathology, Cerrahpasa Medical School, Istanbul, Turkey; Perk Y., Neonatology Unit, Cerrahpaşa Medical School, stanbul, Turkey; Taylan F., Acibadem Genetika, Istanbul, Turkey; Kim P.W., National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, United States; Ilkkan B., Neonatology Unit, Cerrahpaşa Medical School, stanbul, Turkey; Asal G.T., Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey; Goldbach-Mansky R., National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, United States; Sanal O., Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey en_US
dc.description.abstract Deficiency of the IL-1 receptor antagonist (DIRA) is a recently described rare autoinflammatory disease, caused by loss of function mutations in IL1RN leading to the unopposed activation of the IL-1 pathway. We describe a novel nonsense mutation in the IL1RN gene, associated with early intrauterine onset, death and multiorgan involvement in a prematurely born baby. The protein prediction model indicated that the novel Q119X mutation would result in a nonfunctional protein by impairing the ability of the IL-1Ra to bind and antagonize signaling through the IL-1R. Since the disorder may mimic severe bacterial infections and the treatment with anakinra is life saving, we intend to raise awareness of the syndrome and the possibility of a founder mutation that may lead to the diagnosis of additional cases in Turkey. The clinical suspicion of DIRA is critical to avoid improper management of the patients with antibiotics alone and death from multiorgan failure. © 2012 Elsevier Inc. en_US
dc.description.sponsorship National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS, (ZIDAR041180) en_US
dc.identifier.citationcount 45
dc.identifier.doi 10.1016/j.clim.2012.08.003
dc.identifier.endpage 81 en_US
dc.identifier.issn 1521-7035
dc.identifier.issue 1 en_US
dc.identifier.pmid PubMed:22940634
dc.identifier.scopus 2-s2.0-84865474221
dc.identifier.scopusquality Q1
dc.identifier.startpage 77 en_US
dc.identifier.uri https://doi.org/10.1016/j.clim.2012.08.003
dc.identifier.uri https://hdl.handle.net/20.500.14517/2265
dc.identifier.volume 145 en_US
dc.language.iso en
dc.relation.ispartof Clinical Immunology en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.scopus.citedbyCount 48
dc.subject Autoinflammatory syndrome en_US
dc.subject Deficiency of interleukin-1 receptor antagonist en_US
dc.subject Immunodeficiency en_US
dc.subject Intrauterine onset en_US
dc.title A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset en_US
dc.type Article en_US

Files